ImmunoPrecise Antibodies (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, ...
Deep circadian phenotyping across breast cancer cell lines reveals distinct circadian subtypes and their impact on drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback